Insentio

Innocens

Innocens develops an artificial intelligence platform for neonatal intensive care units to detect sepsis and monitor patient deterioration for clinicians and hospitals.

Presymptom Health

This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.

iFAST Diagnositcs

The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.

SurgeCare

The company develops AI-driven blood tests to predict postoperative infection risks for surgical teams and hospitals.

Encultured AI

The company develops artificial intelligence technologies for the healthcare sector to improve patient wellbeing and human-compatible outcomes.

Aisthesis Medical

The company develops artificial intelligence software that predicts sepsis and patient deterioration for hospitals and clinical teams.

Informuta

Informuta develops a predictive software platform using genomic sequencing and artificial intelligence to forecast antibiotic resistance in bacteria for healthcare providers.

Noscendo

This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.